OraSure Technologies/OSUR

$6.89

-5.22%
-
1D1W1MYTD1YMAX

About OraSure Technologies

OraSure Technologies, Inc. is engaged in the development and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. The Company operates through two segments: the Diagnostics segment and the Molecular Solutions segment. The Diagnostics business primarily consists of the development, manufacture, marketing, and sale of simple, easy-to-use diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Molecular Solutions business is operated by Company's subsidiaries, DNA Genotek, Diversigen, and Novosanis. The Molecular Solutions segment products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Ticker

OSUR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Carrie Eglinton Manner

Employees

840

Headquarters

Bethlehem, United States

OSUR Metrics

BasicAdvanced
$534.23M
Market cap
10.09
P/E ratio
$0.72
EPS
0.17
Beta
-
Dividend rate

What the Analysts think about OSUR

Analyst Ratings

Majority rating from 6 analysts.
Hold

Price Targets

Average projection from 4 analysts.
13.35% upside
High $9.00
Low $7.00
$6.89
Current price
$7.81
Average price target

OSUR Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
26.38% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$75.8M
-14.93%
Net income
$20M
80.18%
Profit margin
26.38%
111.89%

OSUR Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 217.65%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.37
-$0.07
$0.15
$0.27
-
Expected
$0.14
-$0.08
$0.04
$0.09
-$0.01
Surprise
170.73%
-8.7%
275%
217.65%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell OraSure Technologies stock

Buy or sell OraSure Technologies stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing